Order results by:
Issue | Title | |
Vol 14, No 1 (2021) | Perspectives of osteoarthritis prevention and therapy personification based on the analysis of comorbid background, genetic polymorphisms and microelement status | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, A. V. Naumov, I. S. Sardaryan, T. E. Bogacheva, T. R. Grishina, I. V. Gogoleva, O. A. Limanova, O. A. Gromova | ||
"... in hair was identified and variants of 120 nucleotide polymorphisms associated with various pathologies ..." | ||
Vol 11, No 1 (2018) | CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation | Abstract similar documents |
A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin | ||
"... are not well studied. Aim.To evaluate the pharmacoeconomic benefits of CYP2D6 polymorphisms genotyping ..." | ||
Vol 14, No 3 (2021) | Modern achievements in pharmacotherapy of osteoarthritis based on endo- and phenotyping | Abstract similar documents |
I. V. Sarvilina, O. A. Shavlovskaya, O. A. Gromova, A. V. Naumov, M. N. Sharov, Yu. S. Prokofyeva | ||
"... остеоартрита с помощью эндои фенотипирования. Рассмотрены последние данные по эпидемиологии остеоартрита разных ..." | ||
Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... Остеоартрит (ОА) – это болезненное и инвалидизирующее заболевание, от которого страдают миллионы ..." | ||
Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
"... потенциальных болезнь модифицирующих остеоартрит препаратов (англ. disease-modifying osteoarthritis drugs ..." | ||
Vol 13, No 4 (2020) | Acute issues in the pharmacotherapy of hand osteoarthritis | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, L. V. Vasilyeva, Ye. F. Yevstratova, А. N. Gromov | ||
"... В статье рассмотрены перспективы фармакологического подхода к терапии остеоартрита кистей рук (ОАК ..." | ||
Vol 16, No 1 (2023) | Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients | Abstract similar documents |
I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova | ||
"... Цель: разработка и верификация шкалы для выявления пациентов с высоким риском остеоартрита (ОА ..." | ||
Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... Остеоартрит (ОА) – это болезненное и инвалидизирующее заболевание, от которого страдают миллионы ..." | ||
Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
"... инъекций) в комплексной терапии остеоартрита (ОА). Материалы и методы. В метаанализ по модели ..." | ||
Vol 15, No 1 (2022) | Application of chondroprotective agents to inhibit osteodestructive processes in the subchondral bone in patients with osteoarthritis | Abstract PDF (Eng) similar documents |
О. А. Gromova, А. М. Lila, I. Yu. Torshin, I. А. Reier | ||
"... Актуальность. Остеоартрит (ОА) сопровождается активацией локального воспаления и не может не ..." | ||
Vol 14, No 3 (2021) | The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure | Abstract similar documents |
M. V. Putilina, N. V. Teplova, O. S. Gerasimova | ||
"... Остеоартрит рассматривается как заболевание периферических суставов и часто игнорируется при ..." | ||
Vol 15, No 1 (2022) | Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
I. Yu. Torshin, T. B. Minasov, N. V. Zagorodniy, A. M. Lila, O. A. Gromova | ||
"... остеоартритом (ОА), у которых исчерпаны возможности фармакотерапии и других способов консервативного ..." | ||
Vol 15, No 3 (2022) | Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) | Abstract similar documents |
I. Yu. Torshin, О. A. Gromova, A. M. Lila | ||
"... Взаимосвязь между патофизиологией остеоартрита (ОА) и метаболическими нарушениями (метаболическим ..." | ||
Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
O. A. Shavlovskaya | ||
"... лечения пациентов с такими заболеваниями суставов и позвоночника, как остеоартрит (ОА), ревматоидный ..." | ||
Vol 13, No 3 (2020) | Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov | ||
"... concentrations (MIC) were established for more than 120 pathogenic bacteria. Results. On average, according ..." | ||
Vol 13, No 2 (2020) | Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? | Abstract similar documents |
A. M. Lila, I. Yu. Torshin, O. A. Gromova | ||
"... Хондроитина сульфат (ХС) и глюкозамина сульфат (ГС) используются в терапии остеоартрита и проявляют ..." | ||
Vol 14, No 4 (2021) | Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, O. A. Gromova | ||
"... глюкозамина сульфата (ГС) в терапии остеоартрита выдвигает повышенные требования к безопасности препаратов ..." | ||
Vol 6, No 2 (2013) | FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS | Abstract similar documents |
A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure | ||
"... – 470 120.40 RUR, which is 51% of the willingness-to-pay threshold in Russia. With the lowest ..." | ||
Vol 9, No 1 (2016) | PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS | Abstract similar documents |
O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina | ||
"... . In recalculation on quantity of patients in Omsk region (120) sum of economy of system of obligatory medical ..." | ||
Vol 10, No 2 (2017) | COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD | Abstract similar documents |
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov | ||
"... / umeclidinum bromide and with olodaterol / tiotropium bromide were 27,541 and 36,120 rubles, respectively ..." | ||
Vol 11, No 2 (2018) | Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer | Abstract similar documents |
G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin | ||
"... a combined treatment. Of these, 120 patients (study group) received hypofractionated radiotherapy (40.5 Gy ..." | ||
Vol 12, No 1 (2019) | Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan | Abstract similar documents |
T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova | ||
"... by 120 million rubles over 5 years. The sensitivity analysis shows the results are robust ..." | ||
Vol 9, No 4 (2016) | THE COSTS OF REGIONAL ANESTHESIA WITH THE USE OF LEVOBUPIVACAINE, RACEMIC BUPIVACAINE AND ROPIVACAINE | Abstract similar documents |
G. E. Ulrikh, A. V. Rudakova | ||
"... .75%. The ropivacaine dose equivalent to 1 mg of levobupivacaine, made when calculating the average of 1.20 mg ..." | ||
Vol 10, No 2 (2017) | COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD | Abstract similar documents |
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov | ||
"... / umeclidinum bromide resulted in improved lung function (an increase in FEV1 by 120% on the 169th day, 0.205 vs ..." | ||
Vol 14, No 2 (2021) | Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation | Abstract similar documents |
D. G. Shchurov, V. S. Dombrovskiy | ||
"... scenario. The smallest ICER values were observed in Scenario 2, and amounted to 112,120 rubles for 1 child ..." | ||
Vol 17, No 1 (2024) | Chemoreactome screening of aquacobalamin and heptamethyl ester of cyanoaquacobyrinic acid cytotoxic effects on tumor cells with experimental confirmation on BT-474 and A549 cell | Abstract similar documents |
I. Yu. Torshin, M. V. Filimonova, O. A. Gromova, L. A. Maiorova, M. A. Sorokina, D. E. Frolova, A. N. Gromov, I. A. Reyer | ||
"... изменялись в достаточно широком диапазоне – от 15 до 2000 нМ. Для 120 из 470 линий клеток (включая ..." | ||
1 - 27 of 27 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)